ConductScience.org, home

Paper2355431

Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy.

Pierce LR and 2 others. JAMA, 1990. Cited by 386 papers, by iCite.

Cite this record

ConductScience Library. Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy. Papers, record 2355431. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2355431

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy.
PubMed
Journal
JAMA
PubMed
Year
1990
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
386
iCite
Relative citation ratio, by iCite
13.9
iCite
Revised in PubMed
2016-10-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pierce LRL R
2Wysowski DKD K
3Gross TPT P

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GemfibrozilMajor topic
LovastatinMajor topic
Muscular DiseasesMajor topic
RhabdomyolysisMajor topic
Acute Kidney Injury
Adult
Aged
Creatine Kinase
Drug Interactions
Drug Therapy, Combination
Female
Humans
Hypercholesterolemia
Male
Middle Aged

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in2243420Myopathy and rhabdomyolysis with lovastatin taken with gemfibrozil.https://conductscience.org/library/papers/2243420

Source PubMed

Download CSV of comments and corrections

Cited by72

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 386 citations.

PMIDTitleJournalYearIn PapersSource
39275243Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review.Nutrients2024https://conductscience.org/library/papers/39275243PubMed
38925925Once-daily Extended-Release Pemafibrate Enhances Adherence and Triglyceride Control Over Twice-Daily Dosing.J Atheroscler Thromb2024https://conductscience.org/library/papers/38925925PubMed
38907023Clinical and pathological aspects of toxic myopathies.J Neurol2024https://conductscience.org/library/papers/38907023PubMed
38776276Outlier analysis for accelerating clinical discovery: An augmented intelligence framework and a systematic review.PLOS Digit Health2024https://conductscience.org/library/papers/38776276PubMed
34219515Statin-Induced Autoimmune Necrotizing Myopathy.J Prim Care Community Health2021https://conductscience.org/library/papers/34219515PubMed
33045618Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK.Atherosclerosis2020https://conductscience.org/library/papers/33045618PubMed
31819247Primary biliary cholangitis: pathogenesis and therapeutic opportunities.Nat Rev Gastroenterol Hepatol2020https://conductscience.org/library/papers/31819247PubMed
31624609Tendon rupture associated with concomitant simvastatin and gemfibrozil use: Biological and pharmacokinetic implications.Clin Case Rep2019https://conductscience.org/library/papers/31624609PubMed
29784023Delayed presentation of severe rhabdomyolysis leading to acute kidney injury following atorvastatin-gemfibrozil combination therapy: a case report.J Med Case Rep2018https://conductscience.org/library/papers/29784023PubMed
28793934Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism.Microbiome2017https://conductscience.org/library/papers/28793934PubMed
26085109Recent Advances in Targeted, Self-Assembling Nanoparticles to Address Vascular Damage Due to Atherosclerosis.Adv Healthc Mater2015https://conductscience.org/library/papers/26085109PubMed
25696757Safety of statins in the new millennium.Neth Heart J2001https://conductscience.org/library/papers/25696757PubMed
25678132Fibrates and cholestasis.Hepatology2015https://conductscience.org/library/papers/25678132PubMed
25131449HDL and cognition in neurodegenerative disorders.Neurobiol Dis2014https://conductscience.org/library/papers/25131449PubMed
24971331Antiartherosclerotic effects of plant flavonoids.Biomed Res Int2014https://conductscience.org/library/papers/24971331PubMed
24897241Phenotype standardization for statin-induced myotoxicity.Clin Pharmacol Ther2014https://conductscience.org/library/papers/24897241PubMed
24668570No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population.Mol Biol Rep2014https://conductscience.org/library/papers/24668570PubMed
24454313Dyslipidemia in patients with chronic and end-stage kidney disease.Cardiorenal Med2013https://conductscience.org/library/papers/24454313PubMed
24083205A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia.J Adv Pharm Technol Res2013https://conductscience.org/library/papers/24083205PubMed
23962548Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease.Clin Gastroenterol Hepatol2014https://conductscience.org/library/papers/23962548PubMed

See all 72 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2355431

GET https://conductscience.org/api/papers/v1/2355431/cited_by?page=2